NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Siddiqui FJ, Venketasubramanian N, Chan ES, Chen C. Efficacy and safety of MLC601 (NeuroAiD), a traditional Chinese medicine, in poststroke recovery: a systematic review. Cerebrovascular Diseases 2013; 35(Supplement 1): 8-17. [PubMed: 23548914]
Abstract
BACKGROUND: Subsequent to a pooled analysis of 2 trials, several more studies have been published assessing the benefit of MLC601 in stroke patients. Hence, it is timely to conduct an updated meta-analysis to frame the interpretation of the results of an ongoing large multicenter, randomized, double-blind, placebo-controlled study. Therefore, we conducted a systematic review of the efficacy of MLC601 in improving the recovery of stroke patients.
METHODS: PubMed® and the Cochrane Library® databases were searched for trials evaluating MLC601 in stroke patients. Primary outcome was functional independence, assessed by the Barthel Index or the Diagnostic Therapeutic Effects of Apoplexy scoring system, item 8. Secondary outcomes were improvement in functional independence scores, motor recovery, reduction in visual field defect and increase in cerebral blood flow. Two authors performed the article selection, appraisal and data extraction while resolving differences through discussion or consulting a third author. Data were analyzed in RevMan5®. Meta-analysis was conducted using a random effects model.
RESULTS: This review included 6 studies with overall low risk of bias but some clinical heterogeneity. MLC601 increased the chances of achieving functional independence after stroke compared to control treatments (risk ratio, 2.35; 95% CI, 1.31-4.23). No deaths and 4 serious adverse events were reported in the MLC601 group, although detail was sparse with inconsistent reporting.
CONCLUSIONS: There is evidence that MLC601 as an add-on to standard treatment could be effective in improving functional independence and motor recovery and is safe for patients with primarily nonacute stable stroke.
Copyright © 2013 S. Karger AG, Basel.
- Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.[Cerebrovasc Dis. 2017]Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study.Venketasubramanian N, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, Gan HH, Baroque Ii AC, Navarro JC, Chang HM, et al. Cerebrovasc Dis. 2017; 43(1-2):36-42. Epub 2016 Nov 15.
- Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.[Cerebrovasc Dis. 2018]Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.Suwanwela NC, Chen CLH, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, Gan HH, Baroque Ii AC, Navarro JC, et al. Cerebrovasc Dis. 2018; 46(1-2):82-88. Epub 2018 Sep 5.
- Review Efficacy of MLC601 on functional recovery after stroke: A systematic review and meta-analysis of randomized controlled trials.[Brain Inj. 2016]Review Efficacy of MLC601 on functional recovery after stroke: A systematic review and meta-analysis of randomized controlled trials.González-Fraile E, Martín-Carrasco M, Ballesteros J. Brain Inj. 2016; 30(3):267-70. Epub 2016 Feb 18.
- Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.[Cerebrovasc Dis. 2020]Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.Venketasubramanian N, Moorakonda RB, Lu Q, Chen CLH, On behalf of the CHIMES Investigators. Cerebrovasc Dis. 2020; 49(2):192-199. Epub 2020 Mar 3.
- Review Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review.[Stroke. 2009]Review Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review.Junhua Z, Menniti-Ippolito F, Xiumei G, Firenzuoli F, Boli Z, Massari M, Hongcai S, Yuhong H, Ferrelli R, Limin H, et al. Stroke. 2009 Aug; 40(8):2797-804. Epub 2009 Jun 25.
- Efficacy and safety of MLC601 (NeuroAiD), a traditional Chinese medicine, in pos...Efficacy and safety of MLC601 (NeuroAiD), a traditional Chinese medicine, in poststroke recovery: a systematic review - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...